A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Clinical trial NCT05781750 · TERMINATED
Trial details
- NCT number
- NCT05781750
- Sponsor
- Kezar Life Sciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-03
- Primary completion
- 2024-11-08
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.